US equities
|
TSLA
$362.44
▲+0.00%
MU
$931.24
▲+0.00%
SPCX
$148.62
▲+0.00%
SNDK
$1,394.83
▲+0.00%
SKHY
$146.11
▲+0.00%
NVDA
$217.23
▲+0.00%
AMD
$562.23
▲+0.00%
INTC
$95.22
▼-0.16%
TSLA
$362.44
▲+0.00%
MU
$931.24
▲+0.00%
SPCX
$148.62
▲+0.00%
SNDK
$1,394.83
▲+0.00%
SKHY
$146.11
▲+0.00%
NVDA
$217.23
▲+0.00%
AMD
$562.23
▲+0.00%
INTC
$95.22
▼-0.16%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Adamas One Corp. - Common Stock
(NQ:
JEWL
)
0.2917
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Adamas One Corp. - Common Stock
< Previous
1
2
Next >
Eiger BioPharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
↗
January 26, 2023
The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...
Via
Benzinga
Global Lab Grown Diamonds Market Projected To Reach $49.9 Billion By 2030
December 21, 2022
Palm Beach, FL – December 21, 2022 – FinancialNewsMedia.com News Commentary – Lab grown diamonds are made in laboratories and factories. These diamonds are identical to natural diamonds in their...
Via
FinancialNewsMedia
Topics
Intellectual Property
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
↗
December 13, 2022
Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
December 14, 2022
On Wednesday, 115 stocks hit new 52-week lows.
Via
Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
↗
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
< Previous
1
2
Next >